beta-lactamase-IN-1

beta-lactamase-IN-1 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:β-Lactamase-IN-1;beta-lactamase-IN-1
CAS:1075237-97-6
Purity:98.00% Package:1 mg;1 mL * 10mM (in DMSO);10 mg;100 mg;200 mg;5 mg;50 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Shanxi Tihondan Pharmaceutical Technology Co., Ltd
Tel: +8618235132063
Email: sales@tihondan.com
Products Intro: Product Name:beta-lactamase inhibitor 1
CAS:1075237-97-6
Purity:95%+ Package:5g;10g;1kg;10kg
Company Name: MedChemexpress LLC  
Tel: 021-58955995
Email: sales@medchemexpress.cn
Products Intro: Product Name:beta-lactamase-IN-1
CAS:1075237-97-6
Purity:>98% Package:1400RMB/1mg
Company Name: Musechem  
Tel: +1-800-259-7612
Email: info@musechem.com
Products Intro: Product Name:beta-lactamase-IN-1
CAS:1075237-97-6
Purity:>98% HPLC Package:10mg;100mg;1g Remarks:Reagent Grade
Company Name: Wuxi AppTec  
Tel: 022-59987777 13552403979
Email: jia_guoqiang@wuxiapptec.com
Products Intro: Product Name:4-(1,3-Dihydroxypropan-2-Yl)-6-Methoxypyrido[2,3-B]Pyrazin-3(4H)-One
CAS:1075237-97-6
Purity:95%+ Package:1G,5G,10G,25G,50G,100G,250G Remarks:in stock
beta-lactamase-IN-1 Basic information
Product Name:beta-lactamase-IN-1
Synonyms:beta-lactamase-IN-1;4-(1,3-Dihydroxypropan-2-Yl)-6-Methoxypyrido[2,3-B]Pyrazin-3(4H)-One;4-(1,3-Dihydroxypropan-2-Yl)-6-Methoxypyrido[2,3-B]Pyrazin-3(4H)-One(WXC01738);beta-lactamase inhibitor 1;β-Lactamase-IN-1;Pyrido[2,3-b]pyrazin-3(4H)-one, 4-[2-hydroxy-1-(hydroxymethyl)ethyl]-6-methoxy-
CAS:1075237-97-6
MF:C11H13N3O4
MW:251.24
EINECS:
Product Categories:
Mol File:1075237-97-6.mol
beta-lactamase-IN-1 Structure
beta-lactamase-IN-1 Chemical Properties
Boiling point 545.5±60.0 °C(Predicted)
density 1.47±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : ≥ 32 mg/mL (127.37 mM)
pka13.68±0.10(Predicted)
form Solid
color Light yellow to khaki
Safety Information
MSDS Information
beta-lactamase-IN-1 Usage And Synthesis
Description

Treating Neisseria gonorrhoeae infection which comprises administering to a subject in need thereof novel Tricyclic nitrogen containing compounds and corresponding pharmaceutical compositions as described herein.

References

[1]. PCT Int. Appl. (2016), WO 2016027249 A1 20160225.

beta-lactamase-IN-1 Preparation Products And Raw materials
Preparation ProductsGepotidacin
Tag:beta-lactamase-IN-1(1075237-97-6) Related Product Information